Delivery Order SPE2DB22D2006-SPE2DB24FV9SF
- Not listed
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The award, valued at $10,633.20, was made to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $14,955.31 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on May 20, 2022, with a completion date of May 23, 2022. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. AmerisourceBergen Drug Corp is a...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,290.33 and is a Firm Fixed Price Delivery Order that runs through August 15, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Otezla 30 mg tablets (60 count) to the Defense Logistics Agency (DLA), a major logistics agency within the U.S. Department of Defense. The contract was awarded to AmerisourceBergen Drug Corp, a large pharmaceutical distribution company, for a ceiling value of $34,985.94 over the contract period ending on April 24, 2024. This is a firm-fixed price delivery order contract, without any set-aside designation. AmerisourceBergen holds a significant...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Otezla 30 mg tablets (60-count) to the U.S. government. The award, valued at $2,544.39, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This single-award IDC serves...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense (DOD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $5,915.39. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of OTEZLA 30 mg tablets in 60-count packages to the U.S. government. The contract has a ceiling value of $22,266.98 and an ultimate completion date of May 7, 2024. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, which is the primary agency responsible for providing logistics and acquisition support for medical commodities to the U.S. Armed Forces and...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $7,842.24 and a completion date of June 9, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp is a subsidiary...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $22,996.75 and a period of performance through July 27, 2023. It is a firm-fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This federal contract award is for the delivery of Otezla 30 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, and the award has a ceiling value of $15,530.10. This is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Cencora,...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV9SFDelivery Order
This federal contract award is for the delivery of Otezla (apremilast) 30 mg tablets to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $7,606.81 and is a firm-fixed price delivery order awarded to Amerisourcebergen Drug Corp, the Corporate Office division of the major pharmaceutical distribution company Amerisourcebergen Corporation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This specific award for Otezla tablets is likely a task order or delivery order placed against that IDC. The contract does not have a set-aside designation, indicating it was awarded on a full and open competition basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.6k | 4/22/24 |